Use of intravenous immunoglobulin and intravenous methylprednisolone in hyperhaemolysis syndrome in sickle cell disease

Hematology

Volumn 9, Issue 5-6, 2004, Pages 433-436

  Win, Nay ^a   Yeghen, Tullie ^b   Needs, Malcolm ^a   Chen, Frederick E ^c   Okpala, Iheanyi ^c  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b WHIPPS CROSS UNIVERSITY HOSPITAL   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Hyperhaemolysis syndrome; IV methylprednisolone; IVIg; Macrophages

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; CEFUROXIME; ERYTHROCYTE ANTIBODY; FLUCLOXACILLIN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; WARFARIN;

ADULT; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CASE REPORT; CELL DESTRUCTION; DISEASE EXACERBATION; DONOR; DRUG POTENTIATION; DRUG USE; FEMALE; HUMAN; HYPERHEMOLYSIS SYNDROME; MACROPHAGE; MALE; MYELOFIBROSIS; PRIORITY JOURNAL; RECIPIENT; SICKLE CELL ANEMIA;

ADULT; ANEMIA, SICKLE CELL; ANTI-INFLAMMATORY AGENTS; FEMALE; HEMOLYSIS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; METHYLPREDNISOLONE;

EID: 12344286824     PISSN: 10245332     EISSN: None     Source Type: Journal    
DOI: 10.1080/10245330400001926     Document Type: Article

References (21)

1. Petz, L.D., Calhoun, L., Shulman, I.A., Johnson, C. and Herron, R.M. (1997) "The sickle cell haemolytic transfusion reaction syndrome", Transfusion 37, 382-392.
2. Win, N., Doughty, H., Telfer, P., Wild, B.J. and Pearson, T.C. (2001) "Hyperhemolytic transfusion reaction", Transfusion 41, 323-328.
3. Friedman, D.F., Kim, H.C. and Manno, C.S. (1993) "Hyperhemolysis associated with red cell transfusion in sickle cell disease (abstract)", Transfusion 33(Suppl.), 14S.
4. Treleaven, J.G. and Win, N. (2004) "Hyperhaemolysis syndrome in a patient with myelofibrosis", Hematology 9, 147-149.
5. Cullis, J.O., Dudley, J.M., Kaye, T. and Win, N. (1995) "Post-transfusion hyperhaemolysis in a patient with sickle cell disease: use of steroids and intravenous immunoglobulin to prevent further red cell destruction", Vox Sanguinis 4, 355-357.
6. Wild, B.J. and Stephens, A.D. (1997) "The use of automated HPLC to detect and quantiate haemoglobins", Clinical and Laboratory 19, 171-176.
7. King, K.E., Shirey, R.S., Lankiewicz, M.W., et al. (1997) "Delayed haemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells", Transfusion 37, 376-381.
8. Aygun, B., Padmanabhan, S., Paley, C. and Chandrasekaran, V. (2002) "Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusion", Transfusion 42, 37-43.
9. Benson, K., Agosti, S.J., Latoni-Benedetti, G.E. and Leparc, G.F. (2003) "Acute and delayed hemolytic transfusion reactions secondary to HLA alloimmunization", Transfusion 43, 753-757.
10. Panzer, S., Matyr W.R., Graninger, W., Puchler, K., Hocker, P. and Lechner, K. (1987) "Haemolytic transfusion reactions due to HLA antibodies. A prospective study combining red cell serology with investigations of Chromium-51-labelled red cell kinetics", The Lancet 28, 474-478.
11. Friedman, D.F., Lukas, M.B., Jawad, A., Larson, P.J., Ohene-Frempong, K. and Manno, C.S. (1996) "Alloimmunization to platelets in heavily transfused patients with sickle cell disease", Blood 88, 3216-3222.
12. Belcher, J.D., Marker, P.H., Weber, J.P., Hebbel, R.P. and Vercellotti, G.M. (2000) "Activated monocytes in sickle cell disease potential role in the activation of vascular endothelium and vaso-occlusion", Blood 96, 2451-2459.
13. Jasinski, M., Pantazopoulos, P., Rother, R.P., van Rooijen, N., Song, W.-C., Molina, H. and Bessler, M. (2004) "A novel mechanism of complement-independent clearance of red cells deficient in glycosyl phosphatidylinositol-linked proteins", Blood 103(7), 2827-2834.
14. Krause, I., Wu, R., Sherer, Y., Patanik, M., Peter, J.B. and Shoenfeld, Y. (2002) "In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations - a potential role for adjuvant intravenous immunoglobulin therapy in infectious disease", Transfusion Medicine 12, 133-139.
15. Rhoades, C.J., Williams, M.A., Kelsey, S.M. and Newland, A.C. (2000) "Monocyte-macrophage system as targets for immunomodulation by intravenous immunoglobulin", Blood Reviews 14, 14-30.
16. Turhan, A., Jenab, P., Bruhns, P., Ravetch, J.V., Coller, B.S. and Frenette, P.S. (2004) "Intravenous immune globulin prevents venula vaso-occlusion in sickle cell mice by inhibiting leukocyte adhesion and the interactions between sickle erythrocytes and adherent leukocytes", Blood 15(103), 2397-2399.
17. Packer, J.T., Greendyke, R.M. and Swisher, S.N. (1960) "The inhibition of erythrophagocytosis in vitro by corticosteroids", Transfusion Association of American Physicians 73, 93-102.
18. Cantu, T.G., Hoehn-Saric, E.W., Burgess, K.M., Racusen, L. and Scheel, P.J. (1995) "Acute renal failure associated with immunoglobulin therapy", American Journal of Kidney Diseases 25 228-234.
19. Gupta, N., Ahmed, I., Nissel-Horowitz, S., Patel, D. and Mehrotra, B. (2001) "Intravenous gammglobulin-associated acute renal failure", American Journal of Hematology 66, 151-152.
20. Go, R.S. and Call, T.G. (2000) "Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous immunoglobulin-related thrombotic complications", Mayo Clinic Proceedings 75, 83-85.
21. Caress, J.B., Cartwright, M.S., Donofrio, P.D. and Peacock, J.E., Jr. (2003) "The clinical features of 16 cases of stroke associated with administration of IVIg", Neurology 60, 1822-1824.